Author:
Hübner Yannis R.,Spuck Nikolai,Berger Moritz,Schlabe Stefan,Rieke Gereon J.,Breitschwerdt Sven,van Bremen Kathrin,Strassburg Christian P.,Gonzalez-Carmona Maria A.,Wasmuth Jan-Christian,Rockstroh Jürgen K.,Boesecke Christoph,Monin Malte B.
Funder
Universitätsklinikum Bonn
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference6 articles.
1. Pilgram L, Appel KS, Ruethrich MM, Koll CEM, Vehreschild MJGT, de Miranda SMN, Hower M, Hellwig K, Hanses F, Wille K, Haselberger M, Spinner CD, Vom Dahl J, Hertenstein B, Westhoff T, Vehreschild JJ, Jensen BO, Stecher M. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study. Infection. 2023. https://doi.org/10.1007/s15010-023-01994-0.
2. Therapeutics and COVID-19: living guideline, 14 July 2022. Geneva: World Health Organization; 2022 (WHO/2019-nCoV/therapeutics/2022.4). Licence: CC BY-NC-SA 3.0 IGO.
3. Rubio-Rivas M, Mora-Luján JM, Formiga F, Arévalo-Cañas C, Lebrón Ramos JM, Villalba García MV, Fonseca Aizpuru EM, Díez-Manglano J, Arnalich Fernández F, Romero Cabrera JL, García García GM, Pesqueira Fontan PM, Vargas Núñez JA, Freire Castro SJ, Loureiro Amigo J, Pascual Pérez MLR, Alcalá Pedrajas JN, Encinas-Sánchez D, Mella Pérez C, Ena J, Gracia Gutiérrez A, Esteban Giner MJ, Varona JF, Millán Núñez-Cortés J, Casas-Rojo JM, SEMI-COVID-19 Network. WHO ordinal scale and inflammation risk categories in COVID-19 comparative study of the severity scales. J Gen Intern Med. 2022;37:1980–7. https://doi.org/10.1007/s11606-022-07511-7.
4. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html. Accessed 03 May 2023.
5. Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, Dutta J, van Bakel H, Aberg J, García-Sastre A, Shah G, Hohl T, Papanicolaou G, Perales MA, Sepkowitz K, Babady NE, Kamboj M. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020;383:2586–8. https://doi.org/10.1056/NEJMc2031670.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献